I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 498.2 ILS -5.46% Market Closed
Market Cap: 239.6m ILS
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
TASE:INCR
Long-Term Debt
â‚Ş102.8m
CAGR 3-Years
192%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Long-Term Debt
$16.5B
CAGR 3-Years
-9%
CAGR 5-Years
-9%
CAGR 10-Years
7%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Long-Term Debt
$6.4m
CAGR 3-Years
58%
CAGR 5-Years
26%
CAGR 10-Years
N/A
S
Seach Medical Group Ltd
TASE:SEMG
Long-Term Debt
â‚Ş13.9m
CAGR 3-Years
92%
CAGR 5-Years
13%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Long-Term Debt
â‚Ş101.8m
CAGR 3-Years
-11%
CAGR 5-Years
5%
CAGR 10-Years
0%
No Stocks Found

InterCure Ltd
Glance View

Market Cap
239.6m ILS
Industry
Pharmaceuticals

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

INCR Intrinsic Value
1 796.79 ILS
Undervaluation 72%
Intrinsic Value
Price
I

See Also

What is InterCure Ltd's Long-Term Debt?
Long-Term Debt
102.8m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Long-Term Debt amounts to 102.8m ILS.

What is InterCure Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
192%

Over the last year, the Long-Term Debt growth was -16%. The average annual Long-Term Debt growth rates for InterCure Ltd have been 192% over the past three years .

Back to Top